Skip to content

Chain Drug Review

NCPA applauds Harris’ focus on PBM reform

NCPA applauds Harris’ focus on PBM reform

“We are very pleased that Vice President Harris is focused on the predatory, anticompetitive companies that are driving up the cost of prescription drugs, driving small, independent pharmacies out of business, and restricting health care access for millions of patients."